Scientific Publications

The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.

Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma
Science Translational Medicine, 2023
Generation and Application of a Living T-Cell Lymphoma Patient-Derived Tumor Xenograft Biorepository
HemaSphere, 2023
A Living Patient-Derived Biorepository Fostering Microenvironment Dissection in T-cell Lymphoma
HemaSphere, 2023
Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma
JCO Precision Oncology, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism
Molecular Carcinogenesis, 2023
Immune-depleted Tumor Microenvironment is Associated With Poor Outcomes and BTK Inhibitor Resistance in Mantle Cell Lymphoma
Hematological Oncology, 2023
Final Result of DIAL (NCI10089), Randomized Phase 2 trial of Varlilumab combined with Nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
Hematological Oncology, 2023
TIGIT is a key inhibitory checkpoint receptor in lymphoma
Journal for ImmunoTherapy of Cancer, 2023
Tumor immunity portrait: An AI-driven molecular predictor combining tumor microenvironment and tumor mutational burden for immune checkpoint inhibitor response prediction
Journal of Clinical Oncology, 2023
RNA sequencing as a confirmatory assay and its impact on patient care in multiple cancer types
Journal of Clinical Oncology, 2023
Contact us